Cough in Reduced True Vocal Fold Mobility

May 11, 2016 updated by: University of Florida

Voluntary Cough Airflow Dynamics and True Vocal Fold Kinematics in Persons With Reduced True Vocal Fold Mobility

This project is a first attempt to assess cough airflow dynamics and true vocal fold (TVF) adduction and abduction angles during voluntary cough to examine the effects of changes in glottal closure due to reduced mobility of one true vocal fold. The hypothesis of this study is that the incomplete glottal closure due to reduced vocal fold mobility will result in changes in true vocal fold adductory and abductory angles during cough and will result in changes to voluntary cough airflow parameters. This study results will contribute to the existing knowledge of the laryngeal contribution to cough airflow dynamics.

Study Overview

Detailed Description

The study investigators will consecutively recruit 30 adults diagnosed with vocal fold insufficiency due to reduced mobility of one true vocal fold.

A questionnaire will be used to collect participants' information. Demographic information such as age, gender, race/ethnicity, height, weight, and a major complaint (dysphonia and/or dysphagia) and medical history information determining the eligibility for participation will be collected from the participant. Participant's medical and surgical history specifically related to the diagnosis and the etiology of reduced vocal fold mobility will be obtained from the participant's medical record.

Videolaryngoscopy will be performed as part of standard clinical care. Vocal fold image and cough airflow will be recorded simultaneously during voluntary cough production with the flexible endoscope in nasopharynx. A second part of the study will include spirometry and expiratory muscle strength assessments. Video images of the vocal fold movement during vowel phonation and cough production will be recorded and stored on a CD for later analysis. The cough airflow recordings will be displayed, stored, and analyzed using LabChart software for Windows.

Study Type

Observational

Enrollment (Actual)

15

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Gainesville, Florida, United States, 32610
        • University of Florida ENT Clinic
      • Gainesville, Florida, United States, 32610
        • University of Florida Speech and Hearing Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The participants will represent a population of patients with glottal insufficiency due to unilateral true vocal fold immobility.

Description

Inclusion Criteria:

  1. Age between 40 and 75 years.
  2. Glottal insufficiency secondary to reduced TVF mobility confirmed with the endoscopic evaluation performed by an otolaryngologist.
  3. The ability to provide informed consent.
  4. No history of chronic obstructive pulmonary disease, lung cancer, and/or lung transplant.
  5. No history of neurodegenerative disease such as Parkinson's disease, multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or progressive supranuclear palsy (PSP), Alzheimer's disease, or dementia.

Exclusion Criteria:

  1. Chest infection within one month prior to the study participation.
  2. History of the adverse reaction associated with laryngoscopy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Laryngeal function in cough
cough airflow measure, vocal tasks, true vocal fold movement, spirometry test, and maximum expiratory pressure (MEP) assessment will be performed in this group.
Participants will produce multiple voluntary coughs for cough airflow assessment.
Other Names:
  • cough airflow assessment
The assessment of glottal closure will be performed during phonation tasks.
Other Names:
  • phonation tasks
The true vocal fold (TVF) movement in cough will be observed and recorded during cough production.
Other Names:
  • TVF movement
The lung function test will require the participant to perform deep inhalations and forceful exhalations into the flow head of the spirometer during spirometry test.
Other Names:
  • spirometry
The assessment of maximum expiratory pressure will require forceful exhalations into a mouthpiece of a manometer during maximum expiratory pressure (MEP) assessment.
Other Names:
  • MEP

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peak expiratory flow rate (PEFR)
Time Frame: baseline
Maximum flow rate in expiratory phase, expressed in liters per second (L/s)
baseline
True vocal fold maximum abduction angles in inspiratory phase
Time Frame: baseline
The TVF maximum abduction angles during cough inspiratory phase of cough will be expressed in degrees.
baseline
True vocal fold maximum abduction angles in expiratory phase
Time Frame: baseline
True vocal fold maximum abduction angles in expiratory phase of cough will be expressed in degrees.
baseline
True vocal fold maximum adduction angles in compression phase
Time Frame: baseline
True vocal fold maximum adduction angles in compression phase of cough will be expressed in degrees.
baseline
Peak expiratory flow rise time (PEFRT)
Time Frame: baseline
Time to reach peak expiratory flow rate expressed in seconds
baseline
Cough volume acceleration (CVA)
Time Frame: baseline
A ratio of peak expiratory flow rate and peak expiratory flow rise time expressed in L/s/s
baseline
Expiratory phase duration
Time Frame: baseline
Duration of expiratory phase of cough expressed in seconds
baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peak expiratory flow
Time Frame: baseline
Maximum flow rate during forced exhalation expressed in L/s
baseline
Maximum expiratory pressure
Time Frame: baseline
Maximum expiratory pressure will be expressed in cmH2O.
baseline
Degree of glottal closure
Time Frame: baseline
The degree of glottal closure will be assessed during phonation using glottic closure rating scale 1-6, 1=complete closure, 6=incomplete closure all along the vocal folds (Södersten et al., 1990).
baseline
Forced vital capacity (FVC)
Time Frame: baseline
Maximum amount of air that can be exhaled with maximal speed and effort after maximum inhalation, expressed in L
baseline
Forced expired volume within 1 second (FEV1)
Time Frame: baseline
Maximum amount of air exhaled forcefully within 1 second, expressed in L.
baseline
The ratio FEV1/FVC
Time Frame: baseline
The percent (%) of forcefully exhaled air that can be exhaled during the first second of exhalation.
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Karen W Hegland, Ph.D., University of Florida

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2015

Primary Completion (Actual)

February 1, 2016

Study Completion (Actual)

February 1, 2016

Study Registration Dates

First Submitted

March 30, 2015

First Submitted That Met QC Criteria

April 1, 2015

First Posted (Estimate)

April 2, 2015

Study Record Updates

Last Update Posted (Estimate)

May 13, 2016

Last Update Submitted That Met QC Criteria

May 11, 2016

Last Verified

May 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Unilateral Vocal Cord Paralysis

Clinical Trials on cough airflow measure

3
Subscribe